PL2133330T3 - Atropoizomer pochodnej pirolu - Google Patents

Atropoizomer pochodnej pirolu

Info

Publication number
PL2133330T3
PL2133330T3 PL08740010T PL08740010T PL2133330T3 PL 2133330 T3 PL2133330 T3 PL 2133330T3 PL 08740010 T PL08740010 T PL 08740010T PL 08740010 T PL08740010 T PL 08740010T PL 2133330 T3 PL2133330 T3 PL 2133330T3
Authority
PL
Poland
Prior art keywords
atropisomer
pyrrole derivative
pyrrole
derivative
Prior art date
Application number
PL08740010T
Other languages
English (en)
Inventor
Kazumasa Aoki
Hiroyuki Tsuruoka
Noriyuki Hayashi
Juri Yoshida
Yusuke Asoh
Original Assignee
Daiichi Sankyo Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Daiichi Sankyo Co Ltd filed Critical Daiichi Sankyo Co Ltd
Publication of PL2133330T3 publication Critical patent/PL2133330T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/34—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PL08740010T 2007-04-09 2008-04-08 Atropoizomer pochodnej pirolu PL2133330T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2007101938 2007-04-09
PCT/JP2008/056907 WO2008126831A1 (ja) 2007-04-09 2008-04-08 ピロール誘導体のアトロプ異性体
EP08740010.7A EP2133330B1 (en) 2007-04-09 2008-04-08 Atropisomer of pyrrole derivative

Publications (1)

Publication Number Publication Date
PL2133330T3 true PL2133330T3 (pl) 2014-06-30

Family

ID=39863928

Family Applications (1)

Application Number Title Priority Date Filing Date
PL08740010T PL2133330T3 (pl) 2007-04-09 2008-04-08 Atropoizomer pochodnej pirolu

Country Status (14)

Country Link
US (2) US8524918B2 (pl)
EP (1) EP2133330B1 (pl)
JP (1) JP5363312B2 (pl)
KR (2) KR101477579B1 (pl)
CN (1) CN101679243B (pl)
BR (1) BRPI0809656B8 (pl)
CA (1) CA2683059C (pl)
DK (1) DK2133330T3 (pl)
ES (1) ES2448498T3 (pl)
IL (1) IL201261A0 (pl)
PL (1) PL2133330T3 (pl)
PT (1) PT2133330E (pl)
TW (1) TWI444185B (pl)
WO (1) WO2008126831A1 (pl)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0920459B1 (pt) * 2008-10-08 2021-12-14 Exelixis, Inc Compostos antagonistas de receptor de mineralocorticoide, composição farmacêutica e método in vitro de inibição da atividade do receptor de mineralocorticoide
AU2009302375B2 (en) * 2008-10-08 2015-03-26 Exelixis, Inc. 1-phenylpyrrole compounds
WO2010098286A1 (ja) * 2009-02-25 2010-09-02 第一三共株式会社 ミネラルコルチコイド受容体拮抗薬を含有する医薬
JP5536869B2 (ja) * 2009-03-26 2014-07-02 ポクセル・エスアーエス 優先晶出法を利用したジヒドロ−１，３，５トリアジンラセミ体のエナンチオマー分離のための方法
CN105164105B (zh) 2013-04-10 2018-01-30 第一三共株式会社 吡咯衍生物的结晶及其制备方法
ES2847904T3 (es) * 2013-07-23 2021-08-04 Daiichi Sankyo Co Ltd Medicamento para la prevención o el tratamiento de la hipertensión
CN105473552B (zh) * 2013-08-27 2017-11-10 第一三共株式会社 用于产生吡咯衍生物及其中间体的方法
EP3160948B1 (en) 2014-06-30 2018-10-24 Astrazeneca AB Benzoxazinone amides as mineralocorticoid receptor modulators
JP6707471B2 (ja) * 2015-01-26 2020-06-10 第一三共株式会社 ピロールカルボキサミドの固形組成物
CN105985295B (zh) * 2015-02-17 2018-11-20 华润赛科药业有限责任公司 一种旋光纯的硫代乙酸类化合物
CN105622531A (zh) 2015-04-03 2016-06-01 南京明德新药研发股份有限公司 轴手性异构体及其制备方法和制药用途
WO2017064121A1 (en) 2015-10-13 2017-04-20 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods and pharmaceutical compositions for the treatment of choroidal neovascularisation
CN108778334A (zh) 2016-03-24 2018-11-09 第三共株式会社 用于治疗肾脏疾病的药物
EP3490606B8 (en) 2016-07-26 2024-04-10 INSERM (Institut National de la Santé et de la Recherche Médicale) Antagonist of mineralocorticoid receptor for the treatment of osteoarthritis
EP3950674A4 (en) 2019-10-25 2022-12-28 Sunshine Lake Pharma Co., Ltd. Pyrrole amide compound and use thereof
JP7697961B2 (ja) 2020-03-11 2025-06-24 アンスティチュ ナショナル ドゥ ラ サンテ エ ドゥ ラ ルシェルシュ メディカル 対象が中心性漿液性脈絡網膜症を有するか、または有する危険性があるかどうかを決定する方法。
US20240376051A1 (en) * 2021-03-30 2024-11-14 Sunshine Lake Pharma Co., Ltd. Crystalline form of pyrrole amide compound, preparation method therefor and use thereof
AU2022264993A1 (en) * 2021-04-26 2023-11-09 Sunshine Lake Pharma Co., Ltd. Preparation method for pyrrole amide compound
WO2023031277A1 (en) 2021-08-31 2023-03-09 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods for the treatment of ocular rosacea
CN115784961B (zh) * 2021-09-10 2026-03-31 上海鼎雅药物化学科技有限公司 埃沙西林酮及其中间体的合成方法
CN119306644A (zh) * 2023-07-12 2025-01-14 广东东阳光药业股份有限公司 制备吡咯甲酸化合物的方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6323208B1 (en) * 1997-09-05 2001-11-27 Pfizer Inc Atropisomers of 2,3-disubstituted-(5.6)-heteroaryl fused-pyrimidin-4-ones
MXPA04002438A (es) * 2001-09-24 2004-06-29 Bayer Pharmaceuticals Corp Preparacion y uso de derivados de pirroll para el tratamiento de la obesidad.
US6939968B2 (en) * 2002-12-23 2005-09-06 Bristol-Myers Squibb Company Atropisomers of 3-substituted-4-arylquinolin-2-one derivatives
DE10354060A1 (de) * 2003-11-19 2005-06-02 Merck Patent Gmbh Pyrrolderivate
CA2573426C (en) * 2004-07-30 2015-11-17 Exelixis, Inc. Pyrrole derivatives as pharmaceutical agents
JP5123668B2 (ja) * 2005-01-10 2013-01-23 エグゼリクシス， インコーポレイテッド 医薬品としての複素環カルボキサミド化合物

Also Published As

Publication number Publication date
IL201261A0 (en) 2010-05-31
HK1139942A1 (en) 2010-09-30
US20140024696A1 (en) 2014-01-23
KR20140048337A (ko) 2014-04-23
CN101679243B (zh) 2012-09-26
BRPI0809656B8 (pt) 2021-05-25
TWI444185B (zh) 2014-07-11
CA2683059A1 (en) 2008-10-23
EP2133330B1 (en) 2014-01-01
EP2133330A1 (en) 2009-12-16
DK2133330T3 (da) 2014-03-31
US8754118B2 (en) 2014-06-17
TW200901968A (en) 2009-01-16
CN101679243A (zh) 2010-03-24
JPWO2008126831A1 (ja) 2010-07-22
ES2448498T3 (es) 2014-03-14
EP2133330A4 (en) 2010-08-11
WO2008126831A1 (ja) 2008-10-23
BRPI0809656A2 (pt) 2014-10-07
US8524918B2 (en) 2013-09-03
BRPI0809656B1 (pt) 2019-07-09
JP5363312B2 (ja) 2013-12-11
PT2133330E (pt) 2014-03-31
US20100093826A1 (en) 2010-04-15
KR101477579B1 (ko) 2014-12-30
KR20090127421A (ko) 2009-12-11
CA2683059C (en) 2012-09-25

Similar Documents

Publication Publication Date Title
PT2133330E (pt) Atropisómero de derivado de pirrole
HUS2400041I1 (hu) 4-Pirimidin-szulfamid-származék
IL211335A0 (en) Pyrrole compounds
TWI429645B (en) Proline derivatives
ZA200908298B (en) Bicycloaniline derivative
PL2239253T3 (pl) Nowe pochodne fenylopirolowe
ZA201006329B (en) Pyrrolidine derivatives
PL2336132T3 (pl) Pochodne morfolinopuryny
EP2269993A4 (en) 2-aminoquinazoline DERIVATIVE
EP2194044A4 (en) QUINOLONE DERIVATIVE
IL208623A0 (en) Cyclopentylacrylamide derivative
IL206875A0 (en) Bicycloamine derivative
IL206576A0 (en) Monosebacate of pyrazole derivative
IL210613A0 (en) Novel acylaminobenzamide derivatives
EP2141168A4 (en) HETEROARYLATED DERIVATIVES
IL208060A0 (en) Bicyclic pyrrole compound
EP2163554A4 (en) PYRIMIDODIAZEPINONE DERIVATIVE
ZA201006992B (en) Hydroxyquinoxalinecarboxamide derivative
ZA201006563B (en) Novel tetrahydroisoquinoline derivative
GB0800762D0 (en) Novel pyridazine derivatives
IL212683A0 (en) Biphenylacetamide derivative
ZA201104310B (en) Pyrrolidines
IL202758A0 (en) Pyrrole derivatives as p2y12 antagonists
EP2228362A4 (en) 4-HYDROXYPHENYLALKYLAMINE DERIVATIVE
ZA200906350B (en) Heteroaryl derivative